Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.1208
0.00 (0.00%)
At close: Aug 20, 2026
Biotricity Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16.4 | 16 | 13.79 | 12.06 | 9.64 | 7.65 | |
Revenue Growth | 13.41% | 16.01% | 14.32% | 25.15% | 26.00% | 126.02% |
Cost of Revenue | 3.04 | 3.05 | 3.23 | 3.71 | 4.2 | 3.08 |
Gross Profit | 13.36 | 12.95 | 10.56 | 8.36 | 5.44 | 4.57 |
Selling, General & Admin | 9.05 | 8.49 | 10.86 | 14.61 | 17.62 | 18.56 |
Research & Development | 2.74 | 2.76 | 2.16 | 2.57 | 3.23 | 2.74 |
Operating Expenses | 11.8 | 11.26 | 13.01 | 17.18 | 20.85 | 21.31 |
Operating Income | 1.57 | 1.69 | -2.45 | -8.83 | -15.41 | -16.74 |
Interest Expense | -4.11 | -4.11 | -5.2 | -5.19 | -2.58 | -6.08 |
Other Non Operating Income (Expenses) | -0.16 | -0.01 | -0.38 | -0.03 | -0.59 | -0.67 |
EBT Excluding Unusual Items | -2.7 | -2.42 | -8.03 | -14.05 | -18.59 | -23.49 |
Other Unusual Items | 0.01 | 0.02 | -0.39 | -0.04 | -0.07 | -5.64 |
Pretax Income | -2.69 | -2.4 | -8.42 | -14.09 | -18.66 | -29.13 |
Net Income | -2.69 | -2.4 | -8.42 | -14.09 | -18.66 | -29.13 |
Preferred Dividends & Other Adjustments | 0.75 | 0.72 | 3.52 | 0.83 | 0.88 | 1.09 |
Net Income to Common | -3.44 | -3.13 | -11.94 | -14.93 | -19.53 | -30.22 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 27 | 27 | 22 | 9 | 9 | 8 |
Shares Outstanding (Diluted) | 27 | 27 | 22 | 9 | 9 | 8 |
Shares Change | 7.96% | 26.85% | 139.38% | 3.83% | 14.32% | 21.13% |
EPS (Basic) | -0.13 | -0.11 | -0.55 | -1.66 | -2.26 | -3.99 |
EPS (Diluted) | -0.13 | -0.11 | -0.55 | -1.66 | -2.26 | -3.99 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 0.16 | -0.72 | -2.38 | -6.69 | -13.55 | -15.19 |
Free Cash Flow Per Share | 0.01 | -0.03 | -0.11 | -0.74 | -1.56 | -2.01 |
Gross Margin | 81.47% | 80.94% | 76.61% | 69.27% | 56.46% | 59.74% |
Operating Margin | 9.56% | 10.57% | -17.76% | -73.18% | -159.87% | -218.77% |
Profit Margin | -21.00% | -19.55% | -86.60% | -123.75% | -202.65% | -395.01% |
Free Cash Flow Margin | 0.99% | -4.49% | -17.26% | -55.49% | -140.55% | -198.60% |
EBITDA | 1.57 | 1.7 | -2.44 | -8.82 | -15.4 | -16.73 |
EBITDA Margin | 9.59% | 10.61% | -17.71% | -73.13% | -159.81% | -218.74% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
EBIT | 1.57 | 1.69 | -2.45 | -8.83 | -15.41 | -16.74 |
EBIT Margin | 9.56% | 10.57% | -17.76% | -73.18% | -159.87% | -218.77% |